发明名称 |
METHODS OF REDUCING LDL-P |
摘要 |
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing LDL-P comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. |
申请公布号 |
US2015157593(A1) |
申请公布日期 |
2015.06.11 |
申请号 |
US201314411835 |
申请日期 |
2013.06.28 |
申请人 |
Amarin Pharmaceuticals ireland Limited |
发明人 |
Braeckman Rene;Soni Paresh;Stirtan William |
分类号 |
A61K31/232;A61J1/03 |
主分类号 |
A61K31/232 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of reducing LDL-P in a subject in need thereof, comprising:
determining a baseline LDL-P level associated with the subject; and thereafter administering to the subject about 1 g to about 4 g of ethyl eicosapentaenoate per day. |
地址 |
Dublin IE |